Global Vendor Scoping & Budget Lead

IQVIA Inc; England; On-site; GBP 90,000 - 130,000; Full time

Job summary

IQVIA seeks a Vendor Scoping Lead to drive end-to-end vendor scoping, budgeting, and outsourcing strategy across global clinical development programs. You will collaborate with Clinical Operations, COLs, study teams, Procurement, and Finance to forecast costs and secure timely governance approvals.

The role demands strong expertise in budgeting, financial modeling, vendor negotiations, and outsourcing governance, balancing quality, timelines, and cost across therapeutic areas.

Qualifications

• Bachelor's degree in Life Sciences, Business Administration, Finance, Supply Chain, or a related discipline.
• Minimum 5 years of experience in pharmaceutical, biotechnology, CRO, or clinical research environments.
• At least 4 years of direct experience in clinical operations, vendor management, outsourcing, procurement, or financial planning.

Responsibilities

• Lead end-to-end vendor scoping, budgeting, and outsourcing activities for global and regional programs.
• Partner with study teams to identify outsourcing requirements and develop vendor engagement strategies.
• Develop, review, and optimize study budgets, ensuring accuracy and alignment with objectives.
• Prepare cost scenarios, budget comparisons, and financial analyses for governance discussions.

Skills

Vendor budgeting

Contract budgeting

Vendor evaluation

Negotiation

Stakeholder management

Excel & analytics

English fluency

Education

Bachelor's degree in Life Sciences / Business / Finance

Tools

Microsoft Office

Excel

Job description

IQVIA seeks a Vendor Scoping Lead to drive end-to-end vendor scoping, budgeting, and outsourcing strategy across global clinical development programs. You will collaborate with Clinical Operations, COLs, study teams, Procurement, and Finance to forecast costs and secure timely governance approvals.

The role demands strong expertise in budgeting, financial modeling, vendor negotiations, and outsourcing governance, balancing quality, timelines, and cost across therapeutic areas.